Abstract
Wnt proteins regulate organ development, tumorigenesis and bone homeostasis, among other functions. The binding of Wnt proteins to plasma membrane receptors on mesenchymal cells induces the differentiation of these cells into the osteoblast lineage and thereby supports bone formation. Wnts are also key signaling proteins in joint remodeling processes. Active Wnt signaling contributes to osteophyte formation and might have an essential role in the anabolic pattern of joint remodeling that is observed in ankylosing spondylitis and osteoarthritis. By contrast, blockade of Wnt signaling facilitates bone erosion and contributes to catabolic joint remodeling, a process that is observed in rheumatoid arthritis. This Review summarizes current knowledge of the molecular regulation of joint remodeling associated with chronic arthritis, focusing on the role of the Wnt proteins and their inhibitors. It also addresses the role of Wnt in determining the differences in clinical presentation of inflammatory arthropathies and discusses implications for future therapy.
Key Points
-
The balance of Wnt proteins and their antagonists is vital in osteoblast differentiation and bone formation
-
Arthritis leads to joint remodeling with either a decrease in local bone mass as observed in rheumatoid arthritis or an increase in local bone mass as observed in ankylosing spondylitis
-
Wnt proteins are crucial in driving osteophytic responses in arthritis, and their antagonists, such as DKK proteins, actively suppress osteophyte formation
-
Activity of Wnt signaling pathways is a key determinant of the pattern of structural remodeling in arthritis
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Schett G et al. (2007) Tumor necrosis factor blockers and structural remodeling in ankylosing spondylitis: what is reality and what is fiction? Ann Rheum Dis 66: 709–711
Lories RJ et al. (2005) Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest 115: 1571–1579
Scharstuhl A et al. (2003) Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoarthritis. Arthritis Rheum 48: 3442–3451
McInnes IB and Schett G (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7: 429–442
Takayanagi H (2007) Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7: 292–304
Gravallese EM et al. (1998) Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 152: 943–951
van Gijn ME et al. (2002) The wnt-frizzled cascade in cardiovascular disease. Cardiovasc Res 55: 16–24
Shimizu H et al. (1997) Transformation by Wnt family proteins correlates with regulation of beta-catenin. Cell Growth Differ 8: 1349–1358
Smalley MJ and Dale TC (1999) Wnt signalling in mammalian development and cancer. Cancer Metastasis Rev 18: 215–230
Cadigan KM and Nusse R (1997) Wnt signaling: a common theme in animal development. Genes Dev 11: 3286–3305
Storm EE and Kingsley DM (1996) Joint patterning defects caused by single and double mutations in members of the bone morphogenetic protein (BMP) family. Development 122: 3969–3979
Hartmann C and Tabin CJ (2001) Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton. Cell 104: 341–351
Pacifici M et al. (2006) Cellular and molecular mechanisms of synovial joint and articular cartilage formation. Ann NY Acad Sci 1068: 74–86
Koyama E et al. (2007) Synovial joint formation during mouse limb skeletogenesis: roles of Indian hedgehog signaling. Ann NY Acad Sci 1116: 100–112
Guo X et al. (2004) Wnt/β-catenin signaling is sufficient and necessary for synovial joint formation. Genes Dev 18: 2404–2417
Settle SH Jr et al. (2003) Multiple joint and skeletal patterning defects caused by single and double mutations in the mouse Gdf6 and Gdf5 genes. Dev Biol 254: 116–130
Niedermaier M et al. (2005) An inversion involving the mouse Shh locus results in brachydactyly through dysregulation of Shh expression. J Clin Invest 115: 900–909
Später D et al. (2006) Wnt9a signaling is required for joint integrity and regulation of Ihh during chondrogenesis. Development 133: 3039–3049
Lane NE et al. (2007) Wnt signaling antagonists are potential prognostic biomarkers for the progression of radiographic hip osteoarthritis in elderly Caucasian women. Arthritis Rheum 56: 3319–3325
Min JL et al. (2005) Association of the Frizzled-related protein gene with symptomatic osteoarthritis at multiple sites. Arthritis Rheum 52: 1077–1080
Loughlin J et al. (2004) Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females. Proc Natl Acad Sci USA 101: 9757–9762
Lamb R et al. (2005) Wnt-1-inducible signaling pathway protein 3 and susceptibility to juvenile idiopathic arthritis. Arthritis Rheum 52: 3548–3553
Urano T et al. (2007) Association of a single nucleotide polymorphism in the WISP1 gene with spinal osteoarthritis in postmenopausal Japanese women. J Bone Miner Metab 25: 253–258
Kerkhof JM et al. (2008) Radiographic osteoarthritis at three joint sites and FRZB, LRP5, and LRP6 polymorphisms in two population-based cohorts. Osteoarthritis Cartilage [10.1016/j.joca.2008.02.007]
Diarra D et al. (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13: 156–163
Sen M et al. (2000) Expression and function of wingless and frizzled homologs in rheumatoid arthritis. Proc Natl Acad Sci USA 97: 2791–2796
Cheon H et al. (2004) Wnt1 inducible signaling pathway protein-3 regulation and microsatellite structure in arthritis. J Rheumatol 31: 2106–2114
Velasquillo C et al. (2007) Expression of MIG-6, WNT-9A, and WNT-7B during osteoarthritis. Ann NY Acad Sci 1117: 175–180
Imai K et al. (2006) Differential expression of WNTs and FRPs in the synovium of rheumatoid arthritis and osteoarthritis. Biochem Biophys Res Commun 345: 1615–1620
Nakamura Y et al. (2005) Expression profiles and functional analyses of Wnt-related genes in human joint disorders. Am J Pathol 167: 97–105
Sen M et al. (2001) Blockade of Wnt-5A/Frizzled 5 signaling inhibits rheumatoid synoviocyte activation. Arthritis Rheum 44: 772–781
Sen M et al. (2002) Regulation of fibronectin and metalloproteinase expression by Wnt signaling in rheumatoid arthritis synoviocytes. Arthritis Rheum 46: 2867–2877
Goldring SR and Goldring MB (2007) Eating bone or adding it: the Wnt pathway decides. Nat Med 13: 133–134
Glass DA et al. (2005) Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8: 751–764
Lories R et al. (2007) Articular cartilage and biomechanical properties of the long bones in Frzb-knockout mice. Arthritis Rheum 56: 4095–4103
Tian E et al. (2003) The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 349: 2483–2494
Benjamin M and McGonagle D (2001) The anatomical basis for disease localisation in seronegative spondylarthropathy at entheses and related sites. J Anat 199: 503–526
Ball J (1971) Enthesopathy of rheumatoid and ankylosing spondylitis. Ann Rheum Dis 30: 213–223
François RJ et al. (2001) Entheses and enthesitis: a histopathologic review and relevance to spondyloarthritides. Curr Opin Rheumatol 13: 255–264
Appel H et al. (2006) Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis. Arthritis Rheum 54: 2845–2851
Dong Y et al. (2005) Wnt-mediated regulation of chondrocyte maturation: modulation by TGF-β. J Cell Biochem 95: 1057–1068
Yano F et al. (2005) The canonical Wnt signaling pathway promotes chondrocyte differentiation in a Sox9-dependent manner. Biochem Biophys Res Commun 333: 1300–1308
Hwang SG et al. (2005) Wnt-3a regulates chondrocyte differentiation via c-Jun/AP-1 pathway. FEBS Lett 579: 4837–4842
Chen M et al. (2008) Inhibition of β-catenin signaling causes defects in postnatal cartilage development. J Cell Sci 121: 1455–1465
Yuasa T et al. (2008) Wnt/β-catenin signaling stimulates matrix catabolic genes and activity in articular chondrocytes: its possible role in joint degeneration. Lab Invest 88: 264–274
Tamamura Y et al. (2005) Developmental regulation of Wnt/beta-catenin signals is required for growth plate assembly, cartilage integrity, and endochondral ossification. J Biol Chem 280: 19185–19195
Enomoto-Iwamoto M et al. (2002) The Wnt antagonist Frzb-1 regulates chondrocyte maturation and long bone development during limb skeletogenesis. Dev Biol 251: 142–156
Kakar S et al. (2007) Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures. J Bone Miner Res 22: 1903–1912
Chen Y et al. (2007) Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing. PLoS Med 4: e249
Dell'accio F et al. (2008) Identification of the molecular response of articular cartilage to injury, by microarray screening: Wnt-16 expression and signaling after injury and in osteoarthritis. Arthritis Rheum 58: 1410–1421
Hwang SG et al. (2004) Wnt-7a causes loss of differentiated phenotype and inhibits apoptosis of articular chondrocytes via different mechanisms. J Biol Chem 279: 26597–26604
Dong YF et al. (2006) Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor. J Cell Physiol 208: 77–86
van der Heijde DM et al. (2006) Two-year etanercept therapy does not inhibit radiographic progression in patients with ankylosing spondylitis. Ann Rheum Dis 65 (Suppl II): 81
Lories RJ et al. (2007) Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis. Arthritis Rheum 56: 489–497
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Schett, G., Zwerina, J. & David, JP. The role of Wnt proteins in arthritis. Nat Rev Rheumatol 4, 473–480 (2008). https://doi.org/10.1038/ncprheum0881
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0881
This article is cited by
-
MicroRNAs-mediated regulation pathways in rheumatic diseases
Inflammopharmacology (2023)
-
Effects of targeted therapies on bone in rheumatic and musculoskeletal diseases
Nature Reviews Rheumatology (2022)
-
Loss of the WNT9a ligand aggravates the rheumatoid arthritis-like symptoms in hTNF transgenic mice
Cell Death & Disease (2021)
-
Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis
Osteoporosis International (2021)
-
Gene–gene interactions of the Wnt/β-catenin signaling pathway in knee osteoarthritis
Molecular Biology Reports (2018)